|
|
News Breaks
|
January 5, 2012
|
| 07:33 EDT |  | RIGL |
| theflyonthewall.com: | Rigel Pharmaceuticals initiates clinical trials for two product candidates | | Rigel Pharmaceuticals announced that two of its lead product candidates entered clinical trials during Q4 2011. The company is evaluating R548, an oral JAK3 inhibitor, as a potential therapeutic for transplant rejection and other systemic immune disorders. The second candidate, R333, is a topical JAK/SYK inhibitor aimed at treating various phases of discoid lupus (lupus of the skin). :theflyonthewall.com |
|
|
News For RIGL From The Last 14 Days Check below for free stories on RIGL the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 16, 2012
|
| 07:32 EDT | | RIGL |
|
|
|
|
|
Subscribe for More Information